Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Comparison of Hartmann's Solution and Normal Saline on Postoperative Blood Glucose and Insulin Levels in Type II Diabetic Patients
The purpose of this study is to determine whether perioperative use of Hartmann's solution in type II diabetes patients increases blood glucose level after surgery. The investigators expect the result to broaden the choice of fluid for diabetic patients and hopefully to diminish the side effects manifested by the excess use of normal saline.
Hyperglycemia is an independent risk factor for poor outcomes in diabetic patients
experiencing sudden cardiac death, myocardial infarction, cerebrovascular accident. During
surgery, activation of the neuroendocrine system by surgical stress releases stress-induced
hormones such as cortisol, glucagon, epinephrine, and growth hormones and it leads to
hepatic glucogenesis and glycogenolysis. Acute perioperative hyperglycemia induces decreased
microvascular reactivity to dilatory agents like bradykinin, increased inflammatory
cytokines, and impaired neutrophil activity. This impaired neuroendocrine and immune system
leads to increased inflammation and multiple organ system dysfunction.
Thomas and Alberti showed postoperative use of 1 litre of Hartmann's solution was associated
with a 7.5 mmol/L increase in plasma glucose concentrations, compared with an increase of
2.1 mmol/L in diabetic patients who received no intravenous fluids. Since then, normal
saline has been preferred over Hartmann's solution in fear of acute hyperglycemia during
postoperative period.
However, a recent review suggested that the maximum increase in glucose concentration with 1
L of Hartmann's solution would be about 1 mmol/L (about 18 mg/dL) ,with a much lower effect
on blood glucose in clinical practice.
In fact, according to 2012 National Health Services (NHS) diabetes guideline for the
perioperative management of the adult patient with diabetes, Hartmann's solution is used in
preference to 0.9% saline. Excess use of normal saline could yield complications such as
hyperglycemia and metabolic acidosis.
To date, a few studies have examined the effects of preoperative blood glucose levels on
outcomes in patients undergoing surgery, and no prospective randomized investigations have
been reported. The investigators are going to find out if Hartmann's solution actually
raises postoperative glucose and insulin level by comparing two groups of diabetic patients
using either Hartmann's solution or normal saline. The investigators expect the result to
broaden the choice of fluid for diabetic patients undergoing surgery and hopefully to
diminish the side effects manifested by the excess use of normal saline.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |